Related Experiment Video
Updated: Jun 14, 2026
14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
15.9K
Dissemination of Circulating Tumor Cells in Breast and Prostate Cancer: Implications for Early Detection
Song Yi Bae1, Kaylee Judith Kamalanathan1, Catalina Galeano-Garces1
1Astrin Biosciences, St. Paul, MN 55114, USA.
Endocrinology
|February 17, 2024
Summary
Early detection of circulating tumor cells (CTCs) is crucial for identifying latent metastasis in breast and prostate cancers. Identifying these early-stage tumor cells improves diagnostics and enables timely interventions for better patient outcomes.
Area of Science:
- Oncology
- Cancer Biology
Background:
- Circulating tumor cells (CTCs) can disseminate early, seeding metastases in cancers like breast and prostate.
- Dormant disseminated tumor cells (DTCs) are a source of late recurrence and therapy resistance.
Approach:
- This review examines the role of early DTCs in latent metastasis in breast and prostate cancer.
- It emphasizes the significance of early CTC detection in these malignancies.
Key Points:
- Early CTC detection correlates with poor prognoses and increased cancer mortality.
- Identifying early-stage CTCs offers potential for early diagnosis and treatment.
- Early detection is vital for curative interventions.
Conclusions:
- Early detection of CTCs is critical for enhancing clinical diagnostics.
- Timely interventions based on early CTC detection can improve patient outcomes.
- Focusing on early CTCs is imperative for managing latent metastasis and improving survival rates.
